Colorectal cancer–associated anaerobes promote tumor aggressiveness by disrupting the epithelial barrier and activating inflammatory pathways
Colorectal cancer (CRC) is intrinsically linked to gut dysbiosis, yet the precise mechanisms by which specific bacterial species contribute to tumor-associated phenotypes remain incompletely understood. Fecal microbiome analysis of CRC patients revealed enrichment of Bacteroides fragilis , Fusobacterium animalis , Parvimonas micra , Peptostreptococcus anaerobius and Peptostreptococcus stomatis compared with healthy controls. Using in vitro models, we found that exposure to these candidate bacteria, particularly F. animalis and B. fragilis , enhanced CRC cell proliferation and induced a pro-inflammatory response characterized by increased IL-8 and CXCL1 secretion. Bacterial exposure also compromised epithelial barrier integrity, as evidenced by increased permeability and reduced expression of the tight junction protein occludin. These changes were accompanied by increased expression of the epithelial-to-mesenchymal transition (EMT)-associated transcription factors SNAI1 and SNAI2 , together with increased migratory capacity. Furthermore, pharmacological inhibition of the urokinase-type plasminogen activator (PLAU) attenuated bacteria-induced CCL5 expression in SW480 cells, suggesting that PLAU-associated signaling may contribute to this inflammatory response under the conditions tested. Overall, these findings suggest that CRC-associated anaerobic bacteria can promote tumor-associated cellular phenotypes through effects on epithelial barrier integrity, inflammatory signaling and EMT-associated processes.
Authors
- Hege Smith Tunsjø (ORCID: https://orcid.org/0000-0002-1114-0717)
- Catuxa Celeiro‐Muñoz
- Alexandra Piñeiro-Teijeiro
- Olalla Ramil‐Gómez (ORCID: https://orcid.org/0000-0002-4675-0961)
- Juan Andrés Vallejo (ORCID: https://orcid.org/0000-0002-7581-8654)
- Margarita Poza (ORCID: https://orcid.org/0000-0001-9423-7268)
- Fernando Fernández‐López (ORCID: https://orcid.org/0000-0001-6132-9641)
- Marta Varela-Eirín (ORCID: https://orcid.org/0000-0002-0281-0678)
- Pablo Aja‐Macaya (ORCID: https://orcid.org/0000-0001-6296-5949)
- Germán Bou (ORCID: https://orcid.org/0000-0001-8837-0062)
- Pilar Fernández Veiga (ORCID: https://orcid.org/0000-0002-3638-6027)
- Inés González‐Castellano (ORCID: https://orcid.org/0000-0003-3334-4523)
- M. Covela (ORCID: https://orcid.org/0000-0003-3360-3070)
- Ana Fernández-Montes
- Angel Concha
- Elena Gallardo-Martín
- María G. Crespo-Leiro
- Sonia Candamio-Folgar
- Paula Nión
- Margarita Reboredo-López
- Olga Maseda-Díaz
- José A. Romero-González
- Begoña Fernández
- Antía Cousillas-Castiñeiras
- José A. Folgueira-Vigo
- Antonio Paz-Millán
- Sara Galindo-Morales
- David Velasco
- Javier Aguirrezabalaga-González
Institutions
- Universidade da Coruña (ES)
- OsloMet – Oslo Metropolitan University (NO)
- Instituto de Salud Carlos III (ES)
- University Hospital Complex Of Vigo (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Centro de Investigación Biomédica en Red (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitario Lucus Augusti (ES)
- Complejo Hospitalario de Pontevedra (ES)
- Instituto de Investigación Biomédica de A Coruña (ES)
- Complejo Hospitalario de Ourense (ES)
- Centro de Investigación Biomédica en Red Enfermedades Infecciosas (ES)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fcimb.2026.1993167
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00